ENERGY-DEPENDENT REDUCED DRUG-BINDING AS A MECHANISM OF VINCA ALKALOID RESISTANCE IN HUMAN-LEUKEMIC LYMPHOBLASTS

  • 1 January 1983
    • journal article
    • research article
    • Vol. 24  (3) , 485-492
Abstract
The accumulation of [3H]vinblastine (VLB) by lines of CCRF-CEM cultured human leukemic lymphoblasts that were either sensitive or resistant to the drug was studied. Neither cell line metabolized VLB nor selectively retained any radioactive impurities. There was an apparent instantaneous accumulation of VLB by cells of both lines, resulting in cell to medium ratios > 1.0 within 1 s after drug addition. Experiments lasting 0-60 s revealed that the presumed undirectional initial of VLB accumulation by resistant cells, termed CEM/VLB100, was .apprx. 1/2 that of sensitive CEM cells. In experiments carried out over 60 min, the VLB-resistent cells accumulated considerably less [3H]VLB than did the sensitive cells. Drug accumulation by both cell lines was temperature-sensitive. CEM/VLB100 cells retained less drug than did CEM cells, apparently because of a larger fraction of readily releasable VLB compared with CEM cells. The accumulation of VLB by either cell line was related in part to cellular levels of ATP. Although depletion of ATP was associated with decreased accumulation of VLB by CEM cells, it was related to enhanced drug accumulation by CEM/VLB100 cells. Restoration of ATP levels to near control values by addition of glucose also had opposite effects on the 2 cell lines. Potentially competing substrates (VM-26, colchicine, daunorubicin and doxorubicin) failed to block this glucose-mediated release of VLB from the CEM/VLB100 cells. In experiments with energy-depleted CEM/VLB100 cells preloaded with VLB and then incubated in drug-free medium, initial drug loss was independent of cellular metabolism, being roughly the same for both metabolically intact and metabolically depleted cells. Glucose (energy) was required only for subseqent release of what appeared to be a more tightly bound cell-associated fraction of VLB. Results of zero-time binding studies tended to confirm that VLB binding by resistant cells has 2 components, one requiring and the other not requiring metabolic energy. Differences in the proportions of these 2 components between the sensitive and resistant cells suggest a mechanism for resistance to VLB and similar compounds.